Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging
Launched by UNIVERSITY OF PENNSYLVANIA · Apr 25, 2024
Trial Information
Current as of November 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new, faster way to take pictures of blood vessel walls using MRI (Magnetic Resonance Imaging). The goal is to see if this quicker method can give us better images to help diagnose conditions related to blood vessels, especially in patients with vasculopathy, which is a disease that affects blood vessels.
To participate in this study, you need to be at least 18 years old and already scheduled for an MRI of your blood vessels as part of your regular medical care. However, if you have certain medical devices in your body, have serious health issues, or are pregnant or breastfeeding, you won't be eligible to join. If you decide to participate, you can expect to undergo a standard MRI scan, but with a new technique that aims to improve the quality of the images taken. This study is currently recruiting participants, and everyone is welcome regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients 18 years of age and scheduled to undergo clinical vessel wall MR imaging exams as part of their standard of care.
- Exclusion Criteria:
- • 1. Any person under the age of 18
- • 2. Presence of artifact-producing intracranial devices (aneurysm clips/coils, ventricular drains, craniectomy mesh, etc.)
- • 3. Any person with contraindications to MRI (medical instability, non-MRI compatible implanted devices, retained metallic foreign bodies, claustrophobia)
- • 4. Large space-occupying lesions (50 mL) or substantial mass effect (herniation, 5mm midline shift) on preceding brain imaging,
- • 5. Imminently life-threatening co-morbid conditions
- • 6. A history of premorbid disabling neurological or psychiatric disease, current substance abuse or remote substance abuse with permanent organic sequelae
- • 7. Pregnancy or lactation
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported